DEPO Financial Facts
Interest and other income: 70KTotal costs and expenses: 31.71M
See Full Income Statement
Common stock, no par value: 213.09M
Deferred license revenue: 3.04M
See Full Balance Sheet
Earnings History for DepoMed Inc. (DEPO)
|
Expand Research on DEPO
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | +37.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | +56.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/5/11  |
Q111 | $1.77 | $1.05 | +$0.72 | $83.1M | $81.42M | N/A / N/A | N/A | -28.3% | Details | |
| 11/5/12 |
 |
Q312 | -$0.03 | -$0.09 | +$0.06 | $33.3M | $30.47M | N/A / N/A | N/A | +1.4% | Details |
| 2/20/13 |
|
Q412 | -$0.07 | -$0.11 | +$0.04 | $26.6M | $26.48M | N/A / N/A | = | -14.1% | Details |
| 5/8/13 |
|
Q113 | -$0.10 | -$0.06 | -$0.04 | $26.2M | $28.93M | N/A / N/A | = | +4.1% | Details |
| 8/1/11 |
|
Q211 | -$0.11 | -$0.05 | -$0.06 | $21.22M | $22.13M | N/A / N/A | N/A | -24.5% | Details |
| 3/3/11 | Q410 | $0.03 | $0.06 | -$0.03 | $20.9M | $22.95M | N/A / N/A | N/A | -33% | Details | |
| 5/8/12 |
Q112 | -$0.16 | -$0.24 | +$0.08 | $16.8M | $12.88M | N/A / N/A | N/A | +1.4% | Details | |
| 11/1/11 |
|
Q311 | -$0.15 | -$0.22 | +$0.07 | $16.52M | $10.4M | N/A / N/A | N/A | +32.2% | Details |
